Literature DB >> 12954478

The foreseeability of real anti-aging medicine: focusing the debate.

Aubrey D N J de Grey1.   

Abstract

There has recently been a sharp and very welcome increase in the rate of appearance of articles discussing the concept of medical interventions that would greatly increase the maximum healthy human lifespan. Much of this literature has emphasised the current non-existence of any such therapies, and has done so with laudable accuracy and authority. Regrettably, however, such articles have frequently extended their ambit to include the issues of how soon such interventions could be developed and of how advisable such an effort would be anyway, and have addressed these much more weakly, thereby diminishing the force of their main message. Here a survey is made of the more conspicuously flawed arguments suggesting tremendous difficulties or dangers in developing such interventions, with the aim thereby to tow those arguments firmly out into the ocean and give them the decent but unambiguous public burial that they so richly deserve. It is hoped that, by clearing the debate on future anti-aging advances of these obfuscations, the many aspects of this topic that have hitherto received much less attention than they warrant will be brought to the fore.

Entities:  

Mesh:

Year:  2003        PMID: 12954478     DOI: 10.1016/s0531-5565(03)00155-4

Source DB:  PubMed          Journal:  Exp Gerontol        ISSN: 0531-5565            Impact factor:   4.032


  3 in total

1.  Like it or not, life-extension research extends beyond biogerontology.

Authors:  Aubrey D N J de Grey
Journal:  EMBO Rep       Date:  2005-11       Impact factor: 8.807

2.  Resistance to debate on how to postpone ageing is delaying progress and costing lives. Open discussions in the biogerontology community would attract public interest and influence funding policy.

Authors:  Aubrey D N J de Grey
Journal:  EMBO Rep       Date:  2005-07       Impact factor: 8.807

3.  Science fact and the SENS agenda. What can we reasonably expect from ageing research?

Authors:  Huber Warner; Julie Anderson; Steven Austad; Ettore Bergamini; Dale Bredesen; Robert Butler; Bruce A Carnes; Brian F C Clark; Vincent Cristofalo; John Faulkner; Leonard Guarente; David E Harrison; Tom Kirkwood; Gordon Lithgow; George Martin; Ed Masoro; Simon Melov; Richard A Miller; S Jay Olshansky; Linda Partridge; Olivia Pereira-Smith; Tom Perls; Arlan Richardson; James Smith; Thomas von Zglinicki; Eugenia Wang; Jeanne Y Wei; T Franklin Williams
Journal:  EMBO Rep       Date:  2005-11       Impact factor: 8.807

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.